Jagsonpal Pharmaceuticals Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 07, 2026

Key Highlights

The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 213.35 as of 07 May 15:30 . The P/E Ratio of Jagsonpal Pharmaceuticals Ltd is 0 as of March 2021 .The P/E Ratio of Novelix Pharmaceuticals Ltd is 0 as of March 2021 . The Market Cap of Jagsonpal Pharmaceuticals Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Novelix Pharmaceuticals Ltd is ₹ 5.48 crore as of March 2021 . The revenue of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 67.37 crore as compare to the Dec '25 revenue of ₹ 75.92 crore. This represent the decline of -11.26% The revenue of Novelix Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 48.4 crore. This represent the decline of -100% The ebitda of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 14.33 crore as compare to the Dec '25 ebitda of ₹ 17.16 crore. This represent the decline of -16.49% The ebitda of Novelix Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 1.31 crore. This represent the decline of -100% The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 5.33 crore to ₹ 8.76 crore over 8 quarters. This represents a CAGR of 28.20% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ -0.35 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Jagsonpal Pharmaceuticals Ltd changed from 15.36 % on March 2021 to 29.99 % on March 2025 . This represents a CAGR of 14.32% over 5 yearsThe Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Jagsonpal Pharmaceuticals Ltd

Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
In 1994, the company has also promoted Aresco Financial Services, a new financial company.

About Novelix Pharmaceuticals Ltd

Novelix Pharmaceuticals Limited was initially incorporated as 'Trimurthi Securities Limited' on December 13, 1994.
The name of the Company was changed from Trimurthi Securities Limited to Trimurthi Drugs & Pharmaceuticals Limited.
Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Limited and again to Trimurthi Limited in May, 2016.
The Company has altered the name to Novelix Pharmaceuticals Limited in 2025. Initially, the company was engaged in finance and investments in securities.
They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.

FAQs for the comparison of Jagsonpal Pharmaceuticals Ltd and Novelix Pharmaceuticals Ltd

Which company has a larger market capitalization, Jagsonpal Pharmaceuticals Ltd or Novelix Pharmaceuticals Ltd?

Market cap of Jagsonpal Pharmaceuticals Ltd is 1,406 Cr while Market cap of Novelix Pharmaceuticals Ltd is 58 Cr

What are the key factors driving the stock performance of Jagsonpal Pharmaceuticals Ltd and Novelix Pharmaceuticals Ltd?

The stock performance of Jagsonpal Pharmaceuticals Ltd and Novelix Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jagsonpal Pharmaceuticals Ltd and Novelix Pharmaceuticals Ltd?

As of May 7, 2026, the Jagsonpal Pharmaceuticals Ltd stock price is INR ₹209.5. On the other hand, Novelix Pharmaceuticals Ltd stock price is INR ₹40.5.

How do dividend payouts of Jagsonpal Pharmaceuticals Ltd and Novelix Pharmaceuticals Ltd compare?

To compare the dividend payouts of Jagsonpal Pharmaceuticals Ltd and Novelix Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.